{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:27:42Z","timestamp":1794014862983,"version":"4.8.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41401-025-01585-9","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T03:55:31Z","timestamp":1749614131000},"page":"3053-3070","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["CD73 inhibitor AB680 suppresses glioblastoma in mice by inhibiting purine metabolism and promoting P2RY12+ microglia transformation"],"prefix":"10.1038","volume":"46","author":[{"given":"Pan-pan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-wen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-wei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En-zhi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-xing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-xin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-dao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-hua","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"1585_CR1","first-page":"299","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 2020;70:299\u2013312.","journal-title":"CA Cancer J Clin"},{"key":"1585_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, et al. Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance. Pharmacol Res. 2021;171:105780.","journal-title":"Pharmacol Res."},{"key":"1585_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2174\/1574892818666230519150401","volume":"19","author":"M Xiong","year":"2024","unstructured":"Xiong M, Chen Z, Zhou C, Yang X, Hu W, Jiang Y, et al. PSMA PET\/MR is a new imaging option for identifying glioma recurrence and predicting prognosis. Recent Pat Anticancer Drug Discov. 2024;19:383\u201395.","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"1585_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wu J, Zhai L, Zhang T, Yin H, Gao H, et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell. 2024;187:294\u2013311.e21.","journal-title":"Cell"},{"key":"1585_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuonc\/nov125","volume":"18","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri S, Zadeh G. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions. Neuro Oncol. 2016;18:160\u201372.","journal-title":"Neuro Oncol"},{"key":"1585_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.683276","volume":"9","author":"JH Garcia","year":"2021","unstructured":"Garcia JH, Jain S, Aghi MK. Metabolic drivers of invasion in glioblastoma. Front Cell Dev Biol. 2021;9:683276.","journal-title":"Front Cell Dev Biol"},{"key":"1585_CR7","doi-asserted-by":"publisher","first-page":"e2599","DOI":"10.1371\/journal.pone.0002599","volume":"3","author":"P Pellegatti","year":"2008","unstructured":"Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F. Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One. 2008;3:e2599.","journal-title":"PLoS One"},{"key":"1585_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188732","volume":"1877","author":"MG Khalafalla","year":"2022","unstructured":"Khalafalla MG, Tran HN, Khalafalla FG. P2Y purinergic signaling in prostate cancer: emerging insights into pathophysiology and therapy. Biochim Biophys Acta Rev Cancer. 2022;1877:188732.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1585_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther. 2021;6:162.","journal-title":"Signal Transduct Target Ther"},{"key":"1585_CR10","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108130","volume":"40","author":"O Kepp","year":"2021","unstructured":"Kepp O, Bezu L, Yamazaki T, Di Virgilio F, Smyth MJ, Kroemer G, et al. ATP and cancer immunosurveillance. Embo J. 2021;40:e108130.","journal-title":"Embo J"},{"key":"1585_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","volume":"17","author":"B Allard","year":"2020","unstructured":"Allard B, Allard D, Buisseret L, Stagg J. The adenosine pathway in immuno-oncology. Nat Rev Clin Oncol. 2020;17:611\u201329.","journal-title":"Nat Rev Clin Oncol"},{"key":"1585_CR12","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1007\/s12035-018-1240-4","volume":"56","author":"JH Azambuja","year":"2019","unstructured":"Azambuja JH, Gelsleichter NE, Beckenkamp LR, Iser IC, Fernandes MC, Figueir\u00f3 F, et al. CD73 downregulation decreases in vitro and in vivo glioblastoma growth. Mol Neurobiol. 2019;56:3260\u201379.","journal-title":"Mol Neurobiol"},{"key":"1585_CR13","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.apsb.2023.12.004","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang J, Zhang W, Zheng M, Guo H, Pan X, et al. The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies. Acta Pharm Sin B. 2024;14:1951\u201364.","journal-title":"Acta Pharm Sin B"},{"key":"1585_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s12035-019-01730-6","volume":"57","author":"JH Azambuja","year":"2020","unstructured":"Azambuja JH, Schuh RS, Michels LR, Gelsleichter NE, Beckenkamp LR, Iser IC, et al. Nasal administration of cationic nanoemulsions as CD73-siRNA delivery system for glioblastoma treatment: a new therapeutical approach. Mol Neurobiol. 2020;57:635\u201349.","journal-title":"Mol Neurobiol"},{"key":"1585_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41591-019-0694-x","volume":"26","author":"S Goswami","year":"2020","unstructured":"Goswami S, Walle T, Cornish AE, Basu S, Anandhan S, Fernandez I, et al. Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma. Nat Med. 2020;26:39\u201346.","journal-title":"Nat Med"},{"key":"1585_CR16","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/jcp.24168","volume":"228","author":"C Quezada","year":"2013","unstructured":"Quezada C, Garrido W, Oyarz\u00fan C, Fern\u00e1ndez K, Segura R, Melo R, et al. 5\u2019-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells. J Cell Physiol. 2013;228:602\u20138.","journal-title":"J Cell Physiol"},{"key":"1585_CR17","doi-asserted-by":"publisher","first-page":"11448","DOI":"10.1021\/acs.jmedchem.0c00525","volume":"63","author":"KV Lawson","year":"2020","unstructured":"Lawson KV, Kalisiak J, Lindsey EA, Newcomb ET, Leleti MR, Debien L, et al. Discovery of AB680: a potent and selective inhibitor of CD73. J Med Chem. 2020;63:11448\u201368.","journal-title":"J Med Chem"},{"key":"1585_CR18","doi-asserted-by":"publisher","first-page":"13444","DOI":"10.1021\/acs.jmedchem.0c01044","volume":"63","author":"JL Jeffrey","year":"2020","unstructured":"Jeffrey JL, Lawson KV, Powers JP. Targeting metabolism of extracellular nucleotides via inhibition of ectonucleotidases CD73 and CD39. J Med Chem. 2020;63:13444\u201365.","journal-title":"J Med Chem"},{"key":"1585_CR19","doi-asserted-by":"crossref","unstructured":"Kim M, Min YK, Jang J, Park H, Lee S, Lee CH. Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer. J Immunother Cancer 2021; 9:e002503.","DOI":"10.1136\/jitc-2021-002503"},{"key":"1585_CR20","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jcmgh.2022.07.005","volume":"14","author":"JY Noh","year":"2022","unstructured":"Noh JY, Lee IP, Han NR, Kim M, Min YK, Lee SY, et al. Additive effect of CD73 inhibitor in colorectal cancer treatment with CDK4\/6 inhibitor through regulation of PD-L1. Cell Mol Gastroenterol Hepatol. 2022;14:769\u201388.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1585_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302498","volume":"10","author":"Q Chen","year":"2023","unstructured":"Chen Q, Yin H, He J, Xie Y, Wang W, Xu H, et al. Tumor microenvironment responsive CD8+ T cells and myeloid-derived suppressor cells to trigger CD73 inhibitor AB680-based synergistic therapy for pancreatic cancer. Adv Sci. 2023;10:e2302498.","journal-title":"Adv Sci."},{"key":"1585_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/2326-6066.CIR-22-0260","volume":"11","author":"C Jacoberger-Foissac","year":"2023","unstructured":"Jacoberger-Foissac C, Cousineau I, Bareche Y, Allard D, Chrobak P, Allard B, et al. CD73 inhibits cGAS-STING and cooperates with CD39 to promote pancreatic cancer. Cancer Immunol Res. 2023;11:56\u201371.","journal-title":"Cancer Immunol Res"},{"key":"1585_CR23","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.cell.2024.01.012","volume":"187","author":"AR Lawrence","year":"2024","unstructured":"Lawrence AR, Canzi A, Bridlance C, Olivi\u00e9 N, Lansonneur C, Catale C, et al. Microglia maintain structural integrity during fetal brain morphogenesis. Cell. 2024;187:962\u201380.e19.","journal-title":"Cell"},{"key":"1585_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00281-023-00987-3","volume":"45","author":"IS Sch\u00e4dlich","year":"2023","unstructured":"Sch\u00e4dlich IS, Winzer R, Stabernack J, Tolosa E, Magnus T, Rissiek B. The role of the ATP-adenosine axis in ischemic stroke. Semin Immunopathol. 2023;45:347\u201365.","journal-title":"Semin Immunopathol"},{"key":"1585_CR25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/glia.22628","volume":"62","author":"CH Shieh","year":"2014","unstructured":"Shieh CH, Heinrich A, Serchov T, van Calker D, Biber K. P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-\u03b1 in cultured mouse microglia. Glia. 2014;62:592\u2013607.","journal-title":"Glia"},{"key":"1585_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105684","volume":"167","author":"B Kenkhuis","year":"2022","unstructured":"Kenkhuis B, Somarakis A, Kleindouwel LRT, van Roon-Mom WMC, H\u00f6llt T, van der Weerd L. Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer\u2019s disease. Neurobiol Dis. 2022;167:105684.","journal-title":"Neurobiol Dis"},{"key":"1585_CR27","doi-asserted-by":"crossref","unstructured":"Allard D, Cousineau I, Ma EH, Allard B, Bareche Y, Fleury H, et al. The CD73 immune checkpoint promotes tumor cell metabolic fitness. Elife. 2023;12:e84508.","DOI":"10.7554\/eLife.84508"},{"key":"1585_CR28","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1172\/JCI128895","volume":"130","author":"SY Neo","year":"2020","unstructured":"Neo SY, Yang Y, Record J, Ma R, Chen X, Chen Z, et al. CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment. J Clin Invest. 2020;130:1185\u201398.","journal-title":"J Clin Invest."},{"key":"1585_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","volume":"19","author":"L Antonioli","year":"2013","unstructured":"Antonioli L, Pacher P, Vizi ES, Hask\u00f3 G. CD39 and CD73 in immunity and inflammation. Trends Mol Med. 2013;19:355\u201367.","journal-title":"Trends Mol Med"},{"key":"1585_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-023-02686-1","volume":"42","author":"F Liu","year":"2023","unstructured":"Liu F, Zhou Q, Jiang HF, Zhang TT, Miao C, Xu XH, et al. Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity. J Exp Clin Cancer Res. 2023;42:118.","journal-title":"J Exp Clin Cancer Res"},{"key":"1585_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.226","volume":"10","author":"F Liu","year":"2020","unstructured":"Liu F, Xu X, Li C, Li C, Li Y, Yin S, et al. Mannose synergizes with chemoradiotherapy to cure cancer via metabolically targeting HIF-1 in a novel triple-negative glioblastoma mouse model. Clin Transl Med. 2020;10:e226.","journal-title":"Clin Transl Med"},{"key":"1585_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41582-022-00679-w","volume":"18","author":"C Horbinski","year":"2022","unstructured":"Horbinski C, Berger T, Packer RJ, Wen PY. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours. Nat Rev Neurol. 2022;18:515\u201329.","journal-title":"Nat Rev Neurol"},{"key":"1585_CR33","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/10717544.2017.1346002","volume":"24","author":"QL Zhang","year":"2017","unstructured":"Zhang QL, Fu BM, Zhang ZJ. Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability. Drug Deliv. 2017;24:1037\u201344.","journal-title":"Drug Deliv"},{"key":"1585_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2021.06.072","volume":"569","author":"F Liu","year":"2021","unstructured":"Liu F, Xu XH, Li CY, Zhang TT, Yin SL, Liu GQ, et al. Rapid tumor recurrence in a novel murine GBM surgical model is associated with Akt\/PD-L1\/vimentin signaling. Biochem Biophys Res Commun. 2021;569:1\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1585_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.7150\/thno.101658","volume":"15","author":"C Li","year":"2025","unstructured":"Li C, Miao C, Ge Y, Wu J, Gao P, Yin S, et al. A molecularly distinct cell type in the midbrain regulates intermale aggression behaviors in mice. Theranostics. 2025;15:707\u201325.","journal-title":"Theranostics"},{"key":"1585_CR36","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s12264-023-01040-x","volume":"39","author":"CY Li","year":"2023","unstructured":"Li CY, Jiang HF, Li L, Lai XJ, Liu QR, Yu SB, et al. Neuroglobin facilitates neuronal oxygenation through tropic migration under hypoxia or anemia in rat: how does the brain breathe? Neurosci Bull. 2023;39:1481\u201396.","journal-title":"Neurosci Bull"},{"key":"1585_CR37","doi-asserted-by":"publisher","first-page":"14.3.1","DOI":"10.1002\/0471250953.bi1413s53","volume":"53","author":"NS Kale","year":"2016","unstructured":"Kale NS, Haug K, Conesa P, Jayseelan K, Moreno P, Rocca-Serra P, et al. MetaboLights: an open-access database repository for metabolomics data. Curr Protoc Bioinform. 2016;53:14.3.1\u2013.3.8.","journal-title":"Curr Protoc Bioinform"},{"key":"1585_CR38","doi-asserted-by":"crossref","unstructured":"Gene Ontology Consortium. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47:D330-d8.","DOI":"10.1093\/nar\/gky1055"},{"key":"1585_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet."},{"key":"1585_CR40","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353\u2013d61.","journal-title":"Nucleic Acids Res"},{"key":"1585_CR41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16:284\u20137.","journal-title":"Omics"},{"key":"1585_CR42","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsd\u00f3ttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739\u201340.","journal-title":"Bioinformatics"},{"key":"1585_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462:108\u201312.","journal-title":"Nature"},{"key":"1585_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock SL, Lopez R, Klein AM. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 2019;8:281\u201391.e9.","journal-title":"Cell Syst"},{"key":"1585_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411\u201320.","journal-title":"Nat Biotechnol"},{"key":"1585_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM, Wadsworth MH 2nd, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352:189\u201396.","journal-title":"Science"},{"key":"1585_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32430-w","volume":"13","author":"S Coy","year":"2022","unstructured":"Coy S, Wang S, Stopka SA, Lin JR, Yapp C, Ritch CC, et al. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. Nat Commun. 2022;13:4814.","journal-title":"Nat Commun"},{"key":"1585_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade3559","volume":"9","author":"R Sun","year":"2023","unstructured":"Sun R, Han R, McCornack C, Khan S, Tabor GT, Chen Y, et al. TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma. Sci Adv. 2023;9:eade3559.","journal-title":"Sci Adv"},{"key":"1585_CR49","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"1585_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"1585_CR51","doi-asserted-by":"publisher","first-page":"9065","DOI":"10.1158\/0008-5472.CAN-09-2307","volume":"69","author":"LA Gravendeel","year":"2009","unstructured":"Gravendeel LA, Kouwenhoven MC, Gevaert O, de Rooi JJ, Stubbs AP, Duijm JE, et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res. 2009;69:9065\u201372.","journal-title":"Cancer Res"},{"key":"1585_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559.","journal-title":"BMC Bioinform"},{"key":"1585_CR53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361.","journal-title":"J Comput Chem"},{"key":"1585_CR54","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1158\/1078-0432.CCR-19-2183","volume":"26","author":"B Sidders","year":"2020","unstructured":"Sidders B, Zhang P, Goodwin K, O\u2019Connor G, Russell DL, Borodovsky A, et al. Adenosine signaling is prognostic for cancer outcome and has predictive utility for immunotherapeutic response. Clin Cancer Res. 2020;26:2176\u201387.","journal-title":"Clin Cancer Res"},{"key":"1585_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118485","volume":"567","author":"L Meng","year":"2019","unstructured":"Meng L, Chu X, Xing H, Liu X, Xin X, Chen L, et al. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol. Int J Pharm. 2019;567:118485.","journal-title":"Int J Pharm"},{"key":"1585_CR56","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"1585_CR57","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrc2818","volume":"10","author":"JT Huse","year":"2010","unstructured":"Huse JT, Holland EC. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer. 2010;10:319\u201331.","journal-title":"Nat Rev Cancer"},{"key":"1585_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12218","volume":"11","author":"T Lu","year":"2022","unstructured":"Lu T, Zhang Z, Zhang J, Pan X, Zhu X, Wang X, et al. CD73 in small extracellular vesicles derived from HNSCC defines tumour-associated immunosuppression mediated by macrophages in the microenvironment. J Extracell Vesicles. 2022;11:e12218.","journal-title":"J Extracell Vesicles"},{"key":"1585_CR59","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.celrep.2019.04.091","volume":"27","author":"I Perrot","year":"2019","unstructured":"Perrot I, Michaud HA, Giraudon-Paoli M, Augier S, Docquier A, Gros L, et al. Blocking antibodies targeting the CD39\/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies. Cell Rep. 2019;27:2411\u201325.e9.","journal-title":"Cell Rep"},{"key":"1585_CR60","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/brain\/aww355","volume":"140","author":"CC Poon","year":"2017","unstructured":"Poon CC, Sarkar S, Yong VW, Kelly JJP. Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis. Brain. 2017;140:1548\u201360.","journal-title":"Brain"},{"key":"1585_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03607-0","volume":"20","author":"C Zhang","year":"2022","unstructured":"Zhang C, Zhou Y, Gao Y, Zhu Z, Zeng X, Liang W, et al. Radiated glioblastoma cell-derived exosomal circ_0012381 induce M2 polarization of microglia to promote the growth of glioblastoma by CCL2\/CCR2 axis. J Transl Med. 2022;20:388.","journal-title":"J Transl Med"},{"key":"1585_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43283-2","volume":"14","author":"B Fu","year":"2023","unstructured":"Fu B, Xiong Y, Sha Z, Xue W, Xu B, Tan S, et al. SEPTIN2 suppresses an IFN-\u03b3-independent, proinflammatory macrophage activation pathway. Nat Commun. 2023;14:7441.","journal-title":"Nat Commun"},{"key":"1585_CR63","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.cell.2018.09.011","volume":"175","author":"X Xu","year":"2018","unstructured":"Xu X, Xu J, Wu J, Hu Y, Han Y, Gu Y, et al. Phosphorylation-mediated IFN-\u03b3R2 membrane translocation is required to activate macrophage innate response. Cell. 2018;175:1336\u201351.e17.","journal-title":"Cell"},{"key":"1585_CR64","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","volume":"181","author":"F Klemm","year":"2020","unstructured":"Klemm F, Maas RR, Bowman RL, Kornete M, Soukup K, Nassiri S, et al. Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells. Cell. 2020;181:1643\u201360.e17.","journal-title":"Cell"},{"key":"1585_CR65","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ccell.2022.12.007","volume":"41","author":"M Kilian","year":"2023","unstructured":"Kilian M, Sheinin R, Tan CL, Friedrich M, Kr\u00e4mer C, Kaminitz A, et al. MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors. Cancer Cell. 2023;41:235\u201351.e9.","journal-title":"Cancer Cell"},{"key":"1585_CR66","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1016\/j.celrep.2018.03.020","volume":"22","author":"DT Utzschneider","year":"2018","unstructured":"Utzschneider DT, Delpoux A, Wieland D, Huang X, Lai CY, Hofmann M, et al. Active maintenance of T cell memory in acute and chronic viral infection depends on continuous expression of FOXO1. Cell Rep. 2018;22:3454\u201367.","journal-title":"Cell Rep"},{"key":"1585_CR67","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2012.01.015","volume":"36","author":"RR Rao","year":"2012","unstructured":"Rao RR, Li Q, Gubbels Bupp MR, Shrikant PA. Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8+ T cell differentiation. Immunity. 2012;36:374\u201387.","journal-title":"Immunity"},{"key":"1585_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0648-1","volume":"16","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Hu X, Liu Y, Dong S, Wen Z, He W, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017;16:79.","journal-title":"Mol Cancer"},{"key":"1585_CR69","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1124\/pharmrev.121.000528","volume":"74","author":"GG Yegutkin","year":"2022","unstructured":"Yegutkin GG, Boison D. ATP and adenosine metabolism in cancer: exploitation for therapeutic gain. Pharmacol Rev. 2022;74:797\u2013822.","journal-title":"Pharmacol Rev."},{"key":"1585_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia C, Yin S, To KKW, Fu L. CD39\/CD73\/A2AR pathway and cancer immunotherapy. Mol Cancer. 2023;22:44.","journal-title":"Mol Cancer"},{"key":"1585_CR71","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/neuonc\/not067","volume":"15","author":"S Xu","year":"2013","unstructured":"Xu S, Shao QQ, Sun JT, Yang N, Xie Q, Wang DH, et al. Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas. Neuro Oncol. 2013;15:1160\u201372.","journal-title":"Neuro Oncol"},{"key":"1585_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq3015","volume":"8","author":"J Stagg","year":"2023","unstructured":"Stagg J, Golden E, Wennerberg E, Demaria S. The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Sci Immunol. 2023;8:eabq3015.","journal-title":"Sci Immunol"},{"key":"1585_CR73","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-immunol-051116-052406","volume":"37","author":"J Linden","year":"2019","unstructured":"Linden J, Koch-Nolte F, Dahl G. Purine release, metabolism, and signaling in the inflammatory response. Annu Rev Immunol. 2019;37:325\u201347.","journal-title":"Annu Rev Immunol"},{"key":"1585_CR74","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.cell.2023.04.022","volume":"186","author":"ST Schafer","year":"2023","unstructured":"Schafer ST, Mansour AA, Schlachetzki JCM, Pena M, Ghassemzadeh S, Mitchell L, et al. An in vivo neuroimmune organoid model to study human microglia phenotypes. Cell. 2023;186:2111\u201326.e20.","journal-title":"Cell"},{"key":"1585_CR75","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/glia.23991","volume":"69","author":"MD Caponegro","year":"2021","unstructured":"Caponegro MD, Oh K, Madeira MM, Radin D, Sterge N, Tayyab M, et al. A distinct microglial subset at the tumor-stroma interface of glioma. Glia. 2021;69:1767\u201381.","journal-title":"Glia"},{"key":"1585_CR76","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, et al. Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17:131\u201343.","journal-title":"Nat Neurosci"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01585-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01585-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01585-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:02:58Z","timestamp":1761292978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01585-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1585"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01585-9","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}